This is the eighth time Switzerland’s research-based pharmaceutical industry has published its annual report based on the Animal Welfare Charter it adopted in 2010. This report includes numerous examples of how Interpharma member companies further improved conditions in animal experiments and the protection of laboratory animals within the meaning of the charter during the year under review.
In this year’s report, there are two core issues: digitization in the field of animal welfare and the national 3Rs competence centre (3RCC). The report also contains numerous examples of projects in the area of the 3Rs (Refine, Reduce, Replace) and presents concrete research projects of various 3Rs Award winners. These projects are aimed at ensuring that animal experiments are less stressful to the animals, reducing the number of animal experiments or replacing animal experiments with alternative methods. In the report, stakeholders from the worlds of politics, animal welfare, industry and academia talk about various topics relevant to the 3Rs.
In addition, the report provides insights into digitization in the field of animal welfare. Using organs-on-a-chip technology, compounds can be tested today on artificially simulated mini-organs. These artificial organs on a chip not only make for better extrapolation of results to humans, but also further the aims of the 3Rs.